Patent · US Active

Generating HPV antigen-specific cells from a naive T cell population

US10934525B2 · kind B2 · utility

1Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2016
Grant dateMar 2, 2021
Priority date—
Expiry dateOct 31, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2502/1157
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Safe, rapid and efficient methods for producing antigen-specific T cells recognizing human papilloma virus or HPV antigens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.